COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Sign Up to like & getrecommendations! Published in 2025 at "Vaccines"
DOI: 10.3390/vaccines13030273
Abstract: Background: As COVID-19 has become an epidemic, we conducted an open-label study aimed to identify immunogenicity and reactogenicity of boosters of the BNT162b2 vaccine in a real-world cohort of long-survivor metastatic lung cancer patients (LS-mLC… read more here.
Keywords: cancer; cohort long; immunogenicity reactogenicity; long survivor ... See more keywords